HALEOS LABS LIMITED
Latest filings
- Haleos Labs 20th AGM: All 8 resolutions passed, FY26 dividend declared · Board & Shareholder Meetings
- 20th AGM held; 15% dividend declared, key resolutions passed · Board & Shareholder Meetings
- Trading Window Closed from Oct 1 for Q2 Results · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on NSE and BSE, reporting revenue of ₹324 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
HALEOSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from HALEOS LABS LIMITED's filed financials and exchange disclosures
What does HALEOS LABS LIMITED do?
HALEOS LABS LIMITED is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol HALEOSLABS.
Is HALEOS LABS LIMITED profitable?
Yes. Over the trailing twelve months HALEOS LABS LIMITED reported a net profit of ₹15 Cr on revenue of ₹324 Cr.
Does HALEOS LABS LIMITED pay a dividend?
Yes. The dividend yield is 0.10% at the current price. It paid out 3% of its profit as dividend in FY26.
Is HALEOS LABS LIMITED debt-free?
No. It reported borrowings of ₹109 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹108 Cr after cash. Debt stands at 0.47× equity. That is higher than 81% of its 166 Pharmaceuticals peers.
Is HALEOS LABS LIMITED expensive compared with its peers?
On trailing P/E, HALEOS LABS LIMITED ranks 73 of 158 in Pharmaceuticals — cheaper than 54% of them, against an industry median of 31.6×. This is a position, not a valuation judgement.
How much does the HALEOS LABS LIMITED share price move in a day?
On a typical session HALEOS LABS LIMITED moves 1.44% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track HALEOS LABS LIMITED's announcements?
Every NSE and BSE filing by HALEOS LABS LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.